Terkko Navigator / Journal of Cystic Fibrosis

Infection with Prevotella nigrescens induces TLR2 signalling and low levels of p65 mediated inflammation in Cystic Fibrosis bronchial epithelial cells

GLPG2737 in lumacaftor/ivacaftor-treated CF subjects homozygous for the F508del mutation: A randomized phase 2A trial (PELICAN)

Pharmacokinetics of colistin after nebulization or intravenous administration of colistin methanesulphonate (Colimycin®) to cystic fibrosis patients

Guidance for computed tomography (CT) imaging of the lungs for patients with cystic fibrosis (CF) in research studies

Micronutrient intake in children with cystic fibrosis in Sydney, Australia

A critical review of definitions used to describe Pseudomonas aeruginosa microbiological status in patients with cystic fibrosis for application in clinical trials

A smartphone application for reporting symptoms in adults with cystic fibrosis improves the detection of exacerbations: Results of a randomised controlled trial

Unwarranted use of intravenous aminoglycosides at UK paediatric cystic fibrosis centres

Human cystic fibrosis monocyte derived macrophages display no defect in acidification of phagolysosomes when measured by optical nanosensors

Single dose escalation studies with inhaled POL6014, a potent novel selective reversible inhibitor of human neutrophil elastase, in healthy volunteers and subjects with cystic fibrosis

The impact of chest computed tomography and chest radiography on clinical management of cystic fibrosis lung disease

Changing epidemiology of the respiratory bacteriology of patients with cystic fibrosis–data from the European cystic fibrosis society patient registry

Whole-blood transcriptomic responses to lumacaftor/ivacaftor therapy in cystic fibrosis

Addressing the burden of illness in adults with cystic fibrosis with screening and triage: An early intervention model of palliative care

Amikacin liposome inhalation suspension for chronic Pseudomonas aeruginosa infection in cystic fibrosis

The presence of Aspergillus fumigatus is associated with worse respiratory quality of life in cystic fibrosis

The association of pediatric cystic fibrosis-related diabetes screening on clinical outcomes by center: A CF patient registry study

Total pancreatectomy with islet autotransplantation in a pancreatic-sufficient cystic fibrosis patient

Automated glycemic control with the bionic pancreas in cystic fibrosis-related diabetes: A pilot study

The impact of CFTR modulator therapies on CF airway microbiology

News

Fair selection of participants in clinical trials: The challenge to push the envelope further

Omalizumab for asthma and allergic bronchopulmonary aspergillosis in adults with cystic fibrosis

Dysregulated insulin in pancreatic insufficient cystic fibrosis with post-prandial hypoglycemia

The role of endothelial cells in cystic fibrosis

Distribution and outcomes of infection of Mycobacterium avium complex species in cystic fibrosis

Risk factors for adverse outcome in infancy in meconium ileus cystic fibrosis infants: A multicentre Italian study

Nasal potential difference in suspected cystic fibrosis patients with 5T polymorphism

Randomized controlled study of aerosolized hypertonic xylitol versus hypertonic saline in hospitalized patients with pulmonary exacerbation of cystic fibrosis

Theranostics by testing CFTR modulators in patient-derived materials: The current status and a proposal for subjects with rare CFTR mutations

Supersonic shear-wave elastography and APRI for the detection and staging of liver disease in pediatric cystic fibrosis

Self-reported alcohol use in the cystic fibrosis community

Speeding up access to new drugs for CF: Considerations for clinical trial design and delivery

A cystic fibrosis child with lung function decline

Taskforce recommends coordinated effort to improve clinical research conduct and find highly effective CFTR-directed treatment for rare mutations

SWATH label-free proteomics for cystic fibrosis research

Urinary metabolomics reveals unique metabolic signatures in infants with cystic fibrosis

Editorial Board

Use of inhaled imipenem/cilastatin in pediatric patients with cystic fibrosis: A case series

Fair subject selection in cystic fibrosis trials

Disease progression in patients with cystic fibrosis treated with ivacaftor: Data from national US and UK registries

Antisense oligonucleotide eluforsen is safe and improves respiratory symptoms in F508DEL cystic fibrosis

Non-fasting bioelectrical impedance analysis in cystic fibrosis: Implications for clinical practice and research

Blood biomarkers to predict short-term pulmonary exacerbation risk in children and adolescents with CF: A pilot study

Highlights from the nutrition guidelines for cystic fibrosis in Australia and New Zealand

News

Omics in CF – Where are we now?

Microbiological evaluation of UV disinfection effectiveness in a specialist cystic fibrosis clinic

The use of antimicrobial susceptibility testing in pediatric cystic fibrosis pulmonary exacerbations

GLPG1837, a CFTR potentiator, in p.Gly551Asp (G551D)-CF patients: An open-label, single-arm, phase 2a study (SAPHIRA1)